Please Wait
Applying Filters...

U.S. Patents

Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GENZYME

02 8GENZYME CORP

03 5KADMON PHARMS LLC

04 1SANOFI

05 23SANOFI AVENTIS US

06 568ABBVIE

07 4ABBVIE ENDOCRINE INC

08 21ALLERGAN

09 702PHARMACYCLICS LLC

10 20ATHENA

11 3DR REDDYS

12 2MISSION PHARMACAL

13 18AUCTA

14 1DOUGLAS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-04-16

DRONEDARONE HYDROCHLORIDE

US Patent Number : 9107900

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1728

Delist Requested :

Patent Use Description : REDUCTION IN RISK OF H...

Patent Expiration Date : 2029-04-16

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2038-12-13

ELIGLUSTAT TARTRATE

US Patent Number : 10888544

Drug Substance Claim :

Drug Product Claim :

Application Number : 205494

Patent Use Code : U-3041

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-13

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2030-10-27

CABAZITAXEL

US Patent Number : 10583110

Drug Substance Claim :

Drug Product Claim :

Application Number : 201023

Patent Use Code : U-2753

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2030-09-14

TERIFLUNOMIDE

US Patent Number : 8802735

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-09-14

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2042-07-14

BELUMOSUDIL MESYLATE

US Patent Number : 12097202

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-4014

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-07-14

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2026-09-12

TERIFLUNOMIDE

US Patent Number : 6794410

Drug Substance Claim :

Drug Product Claim :

Application Number : 202992

Patent Use Code : U-1285

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2026-09-12

Sanofi Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2031-04-27

CABAZITAXEL

US Patent Number : 8927592*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 201023

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-04-27

Sanofi Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2030-12-06

SEVELAMER CARBONATE

US Patent Number : 9095509

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22318

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-06

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-10-30

BELUMOSUDIL MESYLATE

US Patent Number : 8357693

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214783

Patent Use Code : U-3247

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-30

Sanofi Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2027-03-12

TERIFLUNOMIDE

US Patent Number : 6794410*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 202992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-12

Sanofi Company Banner